In silico identification of potential targets and drugs for non-small cell lung cancer

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Lung cancer is a leading cause of mortality globally.
• Cancer arises from genetic alterations affecting oncoproteins and tumor suppressor proteins.
• Identifying novel therapeutic targets and drugs is crucial for lung cancer treatment.

Purpose of the Study:

• To identify differentially expressed genes in lung adenocarcinoma.
• To construct and analyze the lung cancer protein-protein interaction network (PPIN).
• To discover potential therapeutic drugs for lung cancer.

Main Methods:

• Analysis of gene expression datasets from tumor and adjacent non-tumor tissues.
• Integration of microarray, protein-protein interaction, and protein complex data.
• Application of graph theory to PPIN analysis and functional enrichment analysis.
• Utilizing the Connectivity Map web resource for drug discovery.

Main Results:

• Identification of highly dense modules representing potential cancer-associated protein complexes.
• Determination of enriched biological processes and pathways.
• Discovery of eight drugs from DrugBank and three from NCBI with potential to reverse gene expression changes.

Conclusions:

• The study presents a systematic strategy for identifying potential drugs and target genes for lung cancer.
• Network-based analysis of gene expression and protein interactions is a viable approach for drug discovery.
• The identified drugs warrant further investigation for lung cancer therapy.